EFX
30
3
ITW
48
9
ALL
54
6
COF
47
-3
SYY
31
-4
ADP
39
3
IFF
48
-2
LOW
24
-4
PCG
54
-4
MCO
56
3
CNP
70
2
A
37
3
MUR
49
2
NAVI
40
2
XOM
57
-2
AMZN
42
-2
ADT
55
5
YUM
58
2
MAT
30
-2
AZO
48
-2
EFX
30
3
ITW
48
9
ALL
54
6
COF
47
-3
SYY
31
-4
ADP
39
3
IFF
48
-2
LOW
24
-4
PCG
54
-4
MCO
56
3
CNP
70
2
A
37
3
MUR
49
2
NAVI
40
2
XOM
57
-2
AMZN
42
-2
ADT
55
5
YUM
58
2
MAT
30
-2
AZO
48
-2
Financhill
Back

InMed Pharmaceuticals, Inc. 10K Form

Sell
9

INM
InMed Pharmaceuticals, Inc.

Last Price:
$0.64
Seasonality Move:
53.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INM News And Ratings

See the #1 stock for the next 7 days that we like better than INM

INM Financial Statistics

Sales & Book Value

Annual Sales: $4.9M
Cash Flow: $-2.4M
Price / Cash Flow: 0
Annual Sales: $3.42
Price / Book: 0.2

Profitability

EPS (TTM): -3.77800
Net Income (TTM): $-7.7M
Gross Margin: $1.2M
Return on Equity: -80.14%
Return on Assets: -66.17%

InMed Pharmaceuticals, Inc. Earnings Forecast

Key InMed Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 25 years for INM is 23.71%.
  • The Selling, General & Administrative Expenses for INM have been equal to 132.68% of Gross Profit Margin.
  • The Research & Development expenses have been 57.74% of Revenue.
  • The Net Earning history of INM is -165.14% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 15 years.

InMed Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: INM
Website: inmedpharma.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 5.94
Quick Ratio: 4.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INM Technical Analysis vs Fundamental Analysis

Sell
9
InMed Pharmaceuticals, Inc. (INM) is a Sell

Is InMed Pharmaceuticals, Inc. a Buy or a Sell?